1. Home
  2. KN vs OGN Comparison

KN vs OGN Comparison

Compare KN & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knowles Corporation

KN

Knowles Corporation

N/A

Current Price

$32.89

Market Cap

3.2B

ML Signal

N/A

Logo Organon & Co.

OGN

Organon & Co.

N/A

Current Price

$13.82

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KN
OGN
Founded
1946
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.6B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
KN
OGN
Price
$32.89
$13.82
Analyst Decision
Buy
Hold
Analyst Count
4
4
Target Price
★ $44.00
$10.33
AVG Volume (30 Days)
702.7K
★ 2.2M
Earning Date
10-22-2026
11-13-2026
Dividend Yield
N/A
★ 0.58%
EPS Growth
★ 118.94
N/A
EPS
0.58
★ 1.56
Revenue
$593,200,000.00
★ $6,216,000,000.00
Revenue This Year
$16.10
N/A
Revenue Next Year
$8.85
$2.07
P/E Ratio
$60.14
★ $14.52
Revenue Growth
★ 7.17
N/A
52 Week Low
$20.57
$5.69
52 Week High
$42.93
$13.83

Technical Indicators

Market Signals
Indicator
KN
OGN
Relative Strength Index (RSI) 39.77 64.80
Support Level $23.97 $13.72
Resistance Level $36.54 $13.83
Average True Range (ATR) 1.49 0.04
MACD -0.13 0.00
Stochastic Oscillator 24.57 86.96

Price Performance

Historical Comparison
KN
OGN

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: